Cell & Gene Therapy
Prime Medicine news and milestones
Prime Medicine: 11 headlines on record, 2 headlines in the last 90 days. Its story counts 5 milestones.
Data updated Nov 18, 2026 · Back to the company report
11Headlines
2In 90 days
5Milestones
Headlines
Sep 172026
News · kalkineus
Prime Medicine (NASDAQ:PRME) shares jumped sharply this week. Here
Sep 32026
News · markets.businessinsider.com
CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new ...
Aug 62026
News · markets.ft.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Jul 242026
News · markets.businessinsider.com
-- FDA clearance of the IND, together with the previously cleared CTA, establishes a global Phase 1/2 clinical program for PM577a ---- PM577a targ...
Jul 82026
Press release · The Globe and Mail
Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.
Jul 82026
News · seekingalpha.com
Sep 30, 20242024
News · MedCity News
Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 mi…
Feb 20, 20242024
Press release · Nasdaq
--Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its unde…
Jan 8, 20242024
News · Nature
Prime editing enables precise installation of genomic substitutions, insertions and deletions in living systems. Efficient in vitro and in vivo delivery of prime editing componen…
Jan 5, 20242024
Press release · Nasdaq
--Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Alla…
News · fiercebiotech.com
After a year in the shadows, Prime Medicine is breaking cover with 315 million to develop a new kind of gene editing.
Sources: the outlets named on each headline, each story once
Milestones
Oct 2026
Went public NASDAQ: PRME
2025
Team shrank to 9 was 239 · US Form 5500 (plan participants)
Jan 5, 2024
2019
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
Prime Medicine, News. Alion, Nov 18, 2026. https://alion.io/company/primemedicine/news
